102 related articles for article (PubMed ID: 3261197)
1. Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates.
Palombo E; Porrino LJ; Bankiewicz KS; Crane AM; Kopin IJ; Sokoloff L
Brain Res; 1988 Jun; 453(1-2):227-34. PubMed ID: 3261197
[TBL] [Abstract][Full Text] [Related]
2. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
Life Sci; 1987 Apr; 40(17):1657-64. PubMed ID: 3494179
[TBL] [Abstract][Full Text] [Related]
3. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
[TBL] [Abstract][Full Text] [Related]
4. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP.
Palombo E; Porrino LJ; Bankiewicz KS; Crane AM; Sokoloff L; Kopin IJ
J Neurosci; 1990 Mar; 10(3):860-9. PubMed ID: 2319306
[TBL] [Abstract][Full Text] [Related]
5. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5995-9. PubMed ID: 3497401
[TBL] [Abstract][Full Text] [Related]
6. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
Schwartzman RJ; Alexander GM
Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182
[TBL] [Abstract][Full Text] [Related]
7. Acute administration of 1-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a compound producing parkinsonism in humans, stimulates [2-14C]deoxyglucose uptake in the regions of the catecholaminergic cell bodies in the rat and guinea pig brains.
Palacios JM; Wiederhold KH
Brain Res; 1984 May; 301(1):187-91. PubMed ID: 6610458
[TBL] [Abstract][Full Text] [Related]
8. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.
Mochizuki H; Imai H; Endo K; Yokomizo K; Murata Y; Hattori N; Mizuno Y
Neurosci Lett; 1994 Feb; 168(1-2):251-3. PubMed ID: 8028787
[TBL] [Abstract][Full Text] [Related]
9. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
Crossman AR; Mitchell IJ; Sambrook MA
Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
[TBL] [Abstract][Full Text] [Related]
10. Bilateral alterations in local cerebral glucose utilization following intranigral application of the GABAergic agonist muscimol.
Dermon CR; Pizarro P; Georgopoulos P; Savaki HE
J Neurosci; 1990 Sep; 10(9):2861-78. PubMed ID: 2398365
[TBL] [Abstract][Full Text] [Related]
11. Morphine-induced alterations of local cerebral glucose utilization in the basal ganglia of rats.
Beck T; Wenzel J; Kuschinsky K; Krieglstein J
Brain Res; 1989 Sep; 497(2):205-13. PubMed ID: 2684341
[TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys.
Palombo E; Porrino LJ; Crane AM; Bankiewicz KS; Kopin IJ; Sokoloff L
J Neurochem; 1991 May; 56(5):1639-46. PubMed ID: 2013759
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.
Jacobowitz DM; Burns RS; Chiueh CC; Kopin IJ
Psychopharmacol Bull; 1984; 20(3):416-22. PubMed ID: 6332329
[No Abstract] [Full Text] [Related]
15. Distribution of effects of haloperidol on energy metabolism in the rat brain.
McCulloch J; Savaki HE; Sokoloff L
Brain Res; 1982 Jul; 243(1):81-90. PubMed ID: 7116160
[TBL] [Abstract][Full Text] [Related]
16. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate.
Grome JJ; McCulloch J
J Neurochem; 1983 Feb; 40(2):569-76. PubMed ID: 6822839
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
19. Increased uptake of [3H]deoxyglucose and [14C]deoxyglucose in localized regions of the brain during stimulation of the motor cortex.
Goldberg L; Courville J; Lund JP; Kauer JS
Can J Physiol Pharmacol; 1980 Sep; 58(9):1086-91. PubMed ID: 7459699
[TBL] [Abstract][Full Text] [Related]
20. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
Schneider JS; Yuwiler A; Markham CH
Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
